StockIQpro
NASDAQ:NXGL

Nexgel, Inc.

Track all markets on TradingView
Track all markets on TradingView

Nexgel, Inc.'s revenue grew 31.5% in fiscal 2025 to $11.4M while operating margin rose to −29.3%, its highest in 8 years. Free cash flow was −$1.4M, −12.1% of revenue, and the diluted share count rose 20.6%.Summary generated from Nexgel, Inc.'s SEC filings. Latest annual report filed Mar 31, 2026.

Key statistics

Fiscal 2025 from SEC filings. Methodology
Revenue (FY25)$11.4M
Revenue growth+31.5%
Revenue, 5-yr CAGR+76.1%
Gross margin39.5%
Operating margin−29.3%
Net margin−26.3%
ROIC−56.6%
Return on equity−58.7%
Debt / equity0.13
Free cash flow−$1.4M
FCF margin−12.1%
Share count change+20.6%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue224911
Operating income−3−3−3−4−3
Net income−4−5−3−3−3
Free cash flow−3−3−4−4−1

Recent filings

From SEC EDGAR

Peers

Surgical & medical instruments & apparatus